JPWO2020243702A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020243702A5 JPWO2020243702A5 JP2021570170A JP2021570170A JPWO2020243702A5 JP WO2020243702 A5 JPWO2020243702 A5 JP WO2020243702A5 JP 2021570170 A JP2021570170 A JP 2021570170A JP 2021570170 A JP2021570170 A JP 2021570170A JP WO2020243702 A5 JPWO2020243702 A5 JP WO2020243702A5
- Authority
- JP
- Japan
- Prior art keywords
- rnai construct
- nucleotides
- scap
- antisense strand
- antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025176137A JP2026016500A (ja) | 2019-05-30 | 2025-10-20 | ＳＣＡＰ発現を阻害するためのＲＮＡｉコンストラクト及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962854433P | 2019-05-30 | 2019-05-30 | |
| US62/854,433 | 2019-05-30 | ||
| PCT/US2020/035545 WO2020243702A2 (en) | 2019-05-30 | 2020-06-01 | Rnai constructs for inhibiting scap expression and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025176137A Division JP2026016500A (ja) | 2019-05-30 | 2025-10-20 | ＳＣＡＰ発現を阻害するためのＲＮＡｉコンストラクト及びその使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022534402A JP2022534402A (ja) | 2022-07-29 |
| JP2022534402A5 JP2022534402A5 (https=) | 2023-06-05 |
| JPWO2020243702A5 true JPWO2020243702A5 (https=) | 2023-06-05 |
| JP7763104B2 JP7763104B2 (ja) | 2025-10-31 |
Family
ID=71833431
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021570170A Active JP7763104B2 (ja) | 2019-05-30 | 2020-06-01 | ＳＣＡＰ発現を阻害するためのＲＮＡｉコンストラクト及びその使用方法 |
| JP2025176137A Pending JP2026016500A (ja) | 2019-05-30 | 2025-10-20 | ＳＣＡＰ発現を阻害するためのＲＮＡｉコンストラクト及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025176137A Pending JP2026016500A (ja) | 2019-05-30 | 2025-10-20 | ＳＣＡＰ発現を阻害するためのＲＮＡｉコンストラクト及びその使用方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20220307022A1 (https=) |
| EP (1) | EP3976786A2 (https=) |
| JP (2) | JP7763104B2 (https=) |
| KR (1) | KR20220016138A (https=) |
| CN (2) | CN113924368B (https=) |
| AR (1) | AR119061A1 (https=) |
| AU (1) | AU2020284254A1 (https=) |
| BR (1) | BR112021024080A2 (https=) |
| CA (1) | CA3141902A1 (https=) |
| CL (2) | CL2021003169A1 (https=) |
| EA (1) | EA202193296A1 (https=) |
| IL (1) | IL288398A (https=) |
| MX (2) | MX2021014465A (https=) |
| SG (1) | SG11202113112WA (https=) |
| TW (1) | TW202111124A (https=) |
| UY (1) | UY38733A (https=) |
| WO (1) | WO2020243702A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250005108A (ko) * | 2022-04-15 | 2025-01-09 | 다이서나 파마수이티컬, 인크. | Scap 활성을 조절하기 위한 조성물 및 방법 |
| US20250313834A1 (en) * | 2022-05-25 | 2025-10-09 | Amgen Inc. | Rnai constructs for inhibiting scap expression and methods of use thereof |
| IL317824A (en) * | 2022-07-11 | 2025-02-01 | Sanegene Bio Usa Inc | Ribose derivatives modified at the '2' position and methods of use |
| AU2023313321A1 (en) * | 2022-07-27 | 2025-01-09 | E-Therapeutics Plc | Nucleic acid compounds |
| CN117757790A (zh) * | 2022-11-17 | 2024-03-26 | 北京福元医药股份有限公司 | 抑制SCAP基因表达的siRNA、其缀合物和药物组合物及用途 |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| US5719262A (en) | 1993-11-22 | 1998-02-17 | Buchardt, Deceased; Ole | Peptide nucleic acids having amino acid side chains |
| US5714331A (en) | 1991-05-24 | 1998-02-03 | Buchardt, Deceased; Ole | Peptide nucleic acids having enhanced binding affinity, sequence specificity and solubility |
| US5539082A (en) | 1993-04-26 | 1996-07-23 | Nielsen; Peter E. | Peptide nucleic acids |
| DE69233501T2 (de) | 1991-11-22 | 2006-02-23 | Affymetrix, Inc. (n.d.Ges.d.Staates Delaware), Santa Clara | Kombinatorische Strategien für die Polymersynthese |
| US5981505A (en) | 1993-01-26 | 1999-11-09 | The Trustees Of The University Of Pennsylvania | Compositions and methods for delivery of genetic material |
| US5837533A (en) | 1994-09-28 | 1998-11-17 | American Home Products Corporation | Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent |
| US5556752A (en) | 1994-10-24 | 1996-09-17 | Affymetrix, Inc. | Surface-bound, unimolecular, double-stranded DNA |
| US5840710A (en) | 1994-12-09 | 1998-11-24 | Genzyme Corporation | Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |
| US7422902B1 (en) | 1995-06-07 | 2008-09-09 | The University Of British Columbia | Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer |
| US5981501A (en) | 1995-06-07 | 1999-11-09 | Inex Pharmaceuticals Corp. | Methods for encapsulating plasmids in lipid bilayers |
| US5545531A (en) | 1995-06-07 | 1996-08-13 | Affymax Technologies N.V. | Methods for making a device for concurrently processing multiple biological chip assays |
| ATE285477T1 (de) | 1995-06-07 | 2005-01-15 | Inex Pharmaceutical Corp | Herstellung von lipid-nukleinsäure partikeln duch ein hydrophobische lipid-nukleinsäuree komplexe zwischenprodukt und zur verwendung in der gentransfer |
| US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
| US6217900B1 (en) | 1997-04-30 | 2001-04-17 | American Home Products Corporation | Vesicular complexes and methods of making and using the same |
| DE69834038D1 (de) | 1997-07-01 | 2006-05-18 | Isis Pharmaceutical Inc | Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre |
| WO2000003683A2 (en) | 1998-07-20 | 2000-01-27 | Inex Pharmaceuticals Corporation | Liposomal encapsulated nucleic acid-complexes |
| US7833992B2 (en) | 2001-05-18 | 2010-11-16 | Merck Sharpe & Dohme | Conjugates and compositions for cellular delivery |
| US7491805B2 (en) | 2001-05-18 | 2009-02-17 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
| US6693187B1 (en) | 2000-10-17 | 2004-02-17 | Lievre Cornu Llc | Phosphinoamidite carboxlates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
| US7109165B2 (en) | 2001-05-18 | 2006-09-19 | Sirna Therapeutics, Inc. | Conjugates and compositions for cellular delivery |
| US20030130186A1 (en) | 2001-07-20 | 2003-07-10 | Chandra Vargeese | Conjugates and compositions for cellular delivery |
| US9181551B2 (en) | 2002-02-20 | 2015-11-10 | Sirna Therapeutics, Inc. | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
| WO2003093449A2 (en) | 2002-05-06 | 2003-11-13 | Nucleonics, Inc. | Methods for delivery of nucleic acids |
| US8017762B2 (en) | 2003-04-17 | 2011-09-13 | Alnylam Pharmaceuticals, Inc. | Modified iRNA agents |
| DK1620544T3 (en) | 2003-04-17 | 2019-01-14 | Alnylam Pharmaceuticals Inc | MODIFIED iRNA AGENTS |
| US7723509B2 (en) | 2003-04-17 | 2010-05-25 | Alnylam Pharmaceuticals | IRNA agents with biocleavable tethers |
| US7851615B2 (en) | 2003-04-17 | 2010-12-14 | Alnylam Pharmaceuticals, Inc. | Lipophilic conjugated iRNA agents |
| AU2007297388A1 (en) | 2006-09-18 | 2008-03-27 | Alnylam Pharmaceuticals, Inc. | RNAi modulation of scap and therapeutic uses thereof |
| CA2685127C (en) | 2007-04-23 | 2019-01-08 | Alnylam Pharmaceuticals, Inc. | Glycoconjugates of rna interference agents |
| WO2009082607A2 (en) | 2007-12-04 | 2009-07-02 | Alnylam Pharmaceuticals, Inc. | Targeting lipids |
| AR090905A1 (es) | 2012-05-02 | 2014-12-17 | Merck Sharp & Dohme | Conjugados que contienen tetragalnac y peptidos y procedimientos para la administracion de oligonucleotidos, composicion farmaceutica |
| EP3564374A1 (en) | 2013-06-21 | 2019-11-06 | Ionis Pharmaceuticals, Inc. | Compositions and methods for modulation of target nucleic acids |
| IL316808A (en) * | 2014-08-20 | 2025-01-01 | Alnylam Pharmaceuticals Inc | Modified double-stranded RNA materials and their uses |
| WO2017100542A1 (en) * | 2015-12-10 | 2017-06-15 | Alnylam Pharmaceuticals, Inc. | Sterol regulatory element binding protein (srebp) chaperone (scap) irna compositions and methods of use thereof |
| UY37376A (es) | 2016-08-26 | 2018-03-23 | Amgen Inc | Construcciones de arni para inhibir expresión de asgr1 y métodos para su uso |
| BR112019014282A2 (pt) * | 2017-01-10 | 2020-03-03 | Arrowhead Pharmaceuticals, Inc. | Agentes de rnai de antitripsina (aat) alfa-1, composições incluindo agentes de rnai de aat, e métodos de uso |
-
2020
- 2020-06-01 TW TW109118339A patent/TW202111124A/zh unknown
- 2020-06-01 CA CA3141902A patent/CA3141902A1/en active Pending
- 2020-06-01 EA EA202193296A patent/EA202193296A1/ru unknown
- 2020-06-01 CN CN202080041291.2A patent/CN113924368B/zh active Active
- 2020-06-01 UY UY0001038733A patent/UY38733A/es not_active Application Discontinuation
- 2020-06-01 CN CN202510074363.8A patent/CN119842815A/zh active Pending
- 2020-06-01 US US17/615,520 patent/US20220307022A1/en active Pending
- 2020-06-01 JP JP2021570170A patent/JP7763104B2/ja active Active
- 2020-06-01 BR BR112021024080A patent/BR112021024080A2/pt unknown
- 2020-06-01 KR KR1020217042450A patent/KR20220016138A/ko active Pending
- 2020-06-01 SG SG11202113112WA patent/SG11202113112WA/en unknown
- 2020-06-01 AR ARP200101545A patent/AR119061A1/es unknown
- 2020-06-01 EP EP20746771.3A patent/EP3976786A2/en active Pending
- 2020-06-01 AU AU2020284254A patent/AU2020284254A1/en active Pending
- 2020-06-01 WO PCT/US2020/035545 patent/WO2020243702A2/en not_active Ceased
- 2020-06-01 MX MX2021014465A patent/MX2021014465A/es unknown
-
2021
- 2021-11-25 MX MX2026000159A patent/MX2026000159A/es unknown
- 2021-11-25 IL IL288398A patent/IL288398A/en unknown
- 2021-11-29 CL CL2021003169A patent/CL2021003169A1/es unknown
-
2025
- 2025-01-22 CL CL2025000194A patent/CL2025000194A1/es unknown
- 2025-10-20 JP JP2025176137A patent/JP2026016500A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6677679B2 (ja) | 呼吸器疾患関連遺伝子特異的ｓｉＲＮＡ、そのようなｓｉＲＮＡを含む二重らせんオリゴＲＮＡ構造体およびこれを含む呼吸器疾患予防または治療用組成物 | |
| CN104302654B (zh) | 用于调节载脂蛋白(a)表达的方法和组合物 | |
| CN105377887B (zh) | 用于调节载脂蛋白(a)表达的组合物和方法 | |
| US10208309B2 (en) | Double-stranded oligo RNA targeted to amphiregulin and pharmaceutical composition comprising same for preventing or treating fibrosis or respiratory diseases | |
| JP2021506238A5 (https=) | ||
| JP6492053B2 (ja) | 修飾ｔｇｆ−ベータオリゴヌクレオチド | |
| JP2021518125A5 (https=) | ||
| TW202024324A (zh) | 用於抑制17β-HSD第13型(HSD17B13)表現之RNAi藥劑、其組合物及使用方法 | |
| JP2024105284A5 (https=) | ||
| JP2018536689A5 (https=) | ||
| CA3189861A1 (en) | Dux4 inhibitors and methods of use thereof | |
| WO2011081415A2 (ko) | c-Met의 발현을 저해하는 siRNA 및 이를 포함하는 항암 조성물 | |
| JP2022008307A (ja) | 男性型脱毛標的遺伝子の発現を抑制する非対称ｓｉＲＮＡ | |
| CN105722979A (zh) | 肝癌相关的基因特异性siRNA、包含所述siRNA的双链寡RNA分子和包含它们的用于预防或治疗癌症的组合物 | |
| CN108251420A (zh) | 抑制人和动物中CTGF基因表达的siRNA、包含其的组合物及其应用 | |
| JPWO2022036126A5 (https=) | ||
| JP2024002985A (ja) | 膜貫通型セリンプロテアーゼ６（ｔｍｐｒｓｓ６）発現を阻害するための組成物および方法 | |
| JP2021520355A (ja) | Ｔｍ上昇ヌクレオチドで修飾された二本鎖核酸阻害剤分子 | |
| CN118773191A (zh) | 靶向LPA基因的RNAi剂及其用途 | |
| JPWO2020243702A5 (https=) | ||
| JPWO2020123508A5 (https=) | ||
| JP2015532100A (ja) | アンフィレギュリンに特異的な二重鎖オリゴｒｎａ、そのような二重鎖オリゴｒｎａを含む二重鎖オリゴｒｎａの構造体及びこれを含む呼吸器疾患の予防または治療用の組成物 | |
| WO2025077949A1 (zh) | 提升双链寡核苷酸靶基因抑制效果的修饰模板及其组合与应用 | |
| CA3254112A1 (en) | ARNI CONSTRUCTIONS THAT INHIBIT PNPLA3 EXPRESSION AND THEIR METHODS OF USE | |
| JPWO2021126734A5 (https=) |